Investigational Drug Information for TAK-906
✉ Email this page to a colleague
What is the development status for investigational drug TAK-906?
TAK-906 is an investigational drug.
There have been 8 clinical trials for TAK-906.
The most recent clinical trial was a Phase 2 trial, which was initiated on October 17th 2018.
The most common disease conditions in clinical trials are Gastroparesis, Diabetes Mellitus, and [disabled in preview]. The leading clinical trial sponsors are Millennium Pharmaceuticals, Inc., Takeda, and [disabled in preview].
Summary for TAK-906
| US Patents | 0 |
| International Patents | 27 |
| US Patent Applications | 8 |
| WIPO Patent Applications | 2 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 2 (2018-10-17) |
| Vendors | 11 |
Recent Clinical Trials for TAK-906
| Title | Sponsor | Phase |
|---|---|---|
| Bioavailability and Food Effect Study of Two Formulations of TAK-906 | Takeda | Phase 1 |
| A Study to Assess Absolute Bioavailability (ABA) of TAK-906 and to Characterize Mass Balance, Pharmacokinetics (PK), Metabolism, and Excretion of [14C]-TAK-906 in Healthy Male Participants | Millennium Pharmaceuticals, Inc. | Phase 1 |
| A Study to Evaluate the Effect of Single-Dose Intravenous Rifampin as a Prototypic Inhibitor of Organic Anion Transporting Polypeptide (OATP) 1B1 and OATP1B3 on the Single-Dose Pharmacokinetics (PK) of Oral TAK-906 in Healthy Adult Participants | Millennium Pharmaceuticals, Inc. | Phase 1 |
Clinical Trial Summary for TAK-906
Top disease conditions for TAK-906
Top clinical trial sponsors for TAK-906
US Patents for TAK-906
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for TAK-906
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| TAK-906 | Australia | AU2011268073 | 2030-06-18 | ⤷ Sign Up |
| TAK-906 | Canada | CA2802188 | 2030-06-18 | ⤷ Sign Up |
| TAK-906 | China | CN103052636 | 2030-06-18 | ⤷ Sign Up |
| TAK-906 | Cyprus | CY1118541 | 2030-06-18 | ⤷ Sign Up |
| TAK-906 | Denmark | DK2582701 | 2030-06-18 | ⤷ Sign Up |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
